Fuan Pharmaceutical (Group) Dividende
Zukünftiges Wachstum Kriterienprüfungen 4/6
Fuan Pharmaceutical (Group) is a dividend paying company with a current yield of 1.03% that is well covered by earnings.
Wichtige Informationen
1.0%
Dividendenausschüttung
n/a
Rückkaufsrendite
| Gesamte Aktionärsrendite | n/a |
| Zukünftige Dividendenrendite | n/a |
| Wachstum der Dividende | 0.7% |
| Nächster Dividendenzahlungstermin | n/a |
| Ex-Dividendendatum | n/a |
| Dividende pro Aktie | CN¥0.050 |
| Ausschüttungsquote | 22% |
Aktuelle Dividendenentwicklung
Recent updates
Fuan Pharmaceutical (Group) Co., Ltd. (SZSE:300194) Shares Fly 36% But Investors Aren't Buying For Growth
Oct 08
There's No Escaping Fuan Pharmaceutical (Group) Co., Ltd.'s (SZSE:300194) Muted Earnings
Aug 23Does Fuan Pharmaceutical (Group) (SZSE:300194) Have A Healthy Balance Sheet?
Jun 07Fuan Pharmaceutical (Group)'s (SZSE:300194) Shareholders May Want To Dig Deeper Than Statutory Profit
May 02Insufficient Growth At Fuan Pharmaceutical (Group) Co., Ltd. (SZSE:300194) Hampers Share Price
Apr 03Stabilität und Wachstum des Zahlungsverkehrs
Rufe Dividendendaten ab
Stabile Dividende: 300194's dividend payments have been volatile in the past 10 years.
Wachsende Dividende: 300194's dividend payments have increased over the past 10 years.
Dividendenrendite im Vergleich zum Markt
| Fuan Pharmaceutical (Group) Dividendenrendite im Vergleich zum Markt |
|---|
| Segment | Dividendenrendite |
|---|---|
| Unternehmen (300194) | 1.0% |
| Untere 25 % des Marktes (CN) | 0.6% |
| Markt Top 25 % (CN) | 2.2% |
| Branchendurchschnitt (Pharmaceuticals) | 1.7% |
| Analystenprognose (300194) (bis zu 3 Jahre) | n/a |
Bemerkenswerte Dividende: 300194's dividend (1.03%) is higher than the bottom 25% of dividend payers in the CN market (0.57%).
Hohe Dividende: 300194's dividend (1.03%) is low compared to the top 25% of dividend payers in the CN market (2.22%).
Gewinnausschüttung an die Aktionäre
Abdeckung der Erträge: With its low payout ratio (21.8%), 300194's dividend payments are well covered by earnings.
Barausschüttung an die Aktionäre
Cashflow-Deckung: With its reasonably low cash payout ratio (27.1%), 300194's dividend payments are well covered by cash flows.